Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1125 of 3284 entries
View as:

A Study to Assess the Absolute Bioavailability of Oral Selumetinib in Healthy Male Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT02238782 Org: User:
Start: 10/31/14 End: 11/30/14 Due: 11/30/15

Bioequivalence Study in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00844324 Org: User:
Start: 03/31/09 End: 06/30/09 Due: 06/30/10

A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00241449 Org: User:
Start: 11/30/98 End: 01/31/12 Due: 01/31/13

Effectiveness of Atypical Antipsychotics on Anhedonic Features in Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01160679 Org: User:
Start: 08/31/10 End: 08/31/11 Due: 08/31/12

Safety, Tolerability, and Pharmacokinetics of AZD7268 After Single Ascending Oral Doses in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00796965 Org: User:
Start: 12/31/08 End: 03/31/09 Due: 03/31/10

Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates of Once Daily Treatment With Esomeprazole 20mg and Lansoprazole 15mg for 6 Months in Patients Whose EE Has Been Healed

Phase: N/A Priority: Normal
NCT ID: NCT00644735 Org: User:
Start: 12/31/02 End: 01/31/04 Due: 01/31/05

A Study in Healthy Subjects and Mild Asthmatics to Investigate Pharmacokinetics of AZD5423 When Administered in Different Ways

Phase: N/A Priority: Normal
NCT ID: NCT01310322 Org: User:
Start: 04/30/11 End: 10/31/11 Due: 10/31/12

Durvalumab and Tremelimumab as First Line Treatment in Participants With Advanced Hepatocellular Carcinoma (HCC)

Phase: N/A Priority: Normal
NCT ID: NCT05883644 Org: User:
Start: 06/27/23 End: 03/31/26 Due: 03/31/27

Study of Adavosertib(AZD1775) in Japanese Patients With Advanced Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT04462952 Org: User:
Start: 06/24/20 End: 09/22/21 Due: 09/22/22

Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin/1000 mg Metformin XR (Manufactured in Mt Vernon, IN) Relative to 5 mg of Onglyza and 2 × 500 mg Glucophage XR

Phase: N/A Priority: Normal
NCT ID: NCT01192152 Org: User:
Start: 11/30/09 End: 12/31/09 Due: 12/31/10

Reveal the Patterns of Presentation, Management and Outcome of Patients With SCLC and Stage III NSCLC in Saudi Arabia:

Phase: N/A Priority: Normal
NCT ID: NCT04836975 Org: User:
Start: 02/28/22 End: 12/30/22 Due: 12/30/23

Study to Assess Neoadjuvant Durvalumab (D) and Platinum-Based Chemotherapy (CT), Followed by Either Surgery and Adjuvant D or CRT and Consolidation D, in Resectable or Borderline Resectable Stage IIB-IIIB NSCLC (MDT-BRIDGE)

Phase: N/A Priority: Normal
NCT ID: NCT05925530 Org: User:
Start: 02/22/24 End: 08/27/27 Due: 08/27/28

AQUALIS:QoL of CLL Patients Treated With Acalabrutinib in France, Retrospective Study Based on Data From PLATON Database

Phase: N/A Priority: Normal
NCT ID: NCT06548152 Org: User:
Start: 04/28/25 End: 12/31/25 Due: 12/31/26

A Study in Healthy Male Subjects to Understand How Savolitinib Behaves Inside the Body (Pharmacokinetics) When Administered Alone and in Combination With Famotidine

Phase: N/A Priority: Normal
NCT ID: NCT04179071 Org: User:
Start: 12/13/19 End: 03/11/20 Due: 03/11/21

A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04482309 Org: User:
Start: 08/18/20 End: 07/30/27 Due: 07/30/28

A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)

Phase: N/A Priority: Normal
NCT ID: NCT05692180 Org: User:
Start: 04/05/23 End: 05/16/32 Due: 05/16/33

Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib

Phase: N/A Priority: Normal
NCT ID: NCT06899061 Org: User:
Start: 03/25/25 End: 11/19/26 Due: 11/19/27

Phase II Study to Evaluate the Effect of AZD4604 on Airway Inflammation and Biomarkers in Adults With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT06435273 Org: User:
Start: 08/05/24 End: 04/29/26 Due: 04/29/27

Study of Acalabrutinib Versus Chlorambucil Plus Rituximab in Adult Subjects With Previously Untreated Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT04075292 Org: User:
Start: 01/20/20 End: 01/01/27 Due: 01/01/28

MEDI7183 Phase 2 Study in Japanese Ulcerative Colitis Patients

Phase: N/A Priority: Normal
NCT ID: NCT01959165 Org: User:
Start: 11/21/13 End: 04/10/18 Due: 04/10/19

A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Bronchiectasis

Phase: N/A Priority: Normal
NCT ID: NCT00769119 Org: User:
Start: 09/30/08 End: 04/30/09 Due: 04/30/10

A Study to Investigate How Multiple Oral Doses of AZD2389 Affect the Pharmacokinetics of Midazolam, Caffeine, and Bupropion in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06973005 Org: User:
Start: 05/08/25 End: 07/04/25 Due: 07/04/26

A US Study to Evaluate Transarterial Radioembolization (TARE) in Combination With Durvalumab and Bevacizumab Therapy in People With Unresectable Hepatocellular Carcinoma Amenable to TARE

Phase: N/A Priority: Normal
NCT ID: NCT06040099 Org: User:
Start: 02/13/24 End: 10/23/26 Due: 10/23/27

A Study to Investigate the Effect of Food on Balcinrenone/Dapagliflozin Pharmacokinetics in Fed and Fasted State and Pharmacokinetics of Balcinrenone When Dosed With a P-gp Inhibitor in Healthy Participants.

Phase: N/A Priority: Normal
NCT ID: NCT06979388 Org: User:
Start: 05/20/25 End: 08/19/25 Due: 08/19/26

Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT06651970 Org: User:
Start: 02/04/25 End: 08/16/30 Due: 08/16/31